Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 74 Precursor Cell Lymphoblastic Leukemia-Lymphoma 28 Burkitt Lymphoma 25 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11 Recurrence 8 Immunoglobulin Light-chain Amyloidosis 8 Vomiting 7 Nausea 7 Lymphoma, Mantle-Cell 7 Leukemia, Biphenotypic, Acute 7 Lymphoma, Large B-Cell, Diffuse 6 Lymphoma 6 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasms 5 Lymphoma, Non-Hodgkin 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Hodgkin Disease 5 Smoldering Multiple Myeloma 4 Neoplasms, Plasma Cell 4 Neoplasm Metastasis 4 Breast Neoplasms 4 Blast Crisis 4 Prostatic Neoplasms 3 Plasmacytoma 3 Ovarian Neoplasms 3 Myelodysplastic Syndromes 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Lung Neoplasms 3

Interventions

dexamethasone acetate 1 dexamethasone 21-phosphate 1 Etoricoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Somatoform Disorders × dexamethasone acetate × Clear all

NCT03348696 2020-01-09

REaCT-TAPS

Ottawa Hospital Research Institute

Phase 4 Completed

Breast Neoplasms, Somatoform Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡